Table 4: Antimicrobial susceptibility pattern of ESBL producing urinary isolates.
| Drug |
Sensitive n (%) |
Intermediate n (%) |
Resistance n (%) |
| Ampicillin |
3 (10.3) |
4 (13.8) |
22 (75.9) |
| Amoxicillin/clavulanate |
13 (44.8) |
4 (13.8) |
12 (41.4) |
| Ceftriaxone |
19 (65.5) |
1 (3.4) |
9 (31) |
| Cefotaxime |
10 (34.5) |
2 (6.8) |
17 (58.7) |
| Ciprofloxacin |
15 (51.7) |
0 (0.0) |
14 (48.3) |
| Levofloxacin |
17 (58.6) |
0 (0.0) |
12 (41.4) |
| Co-trimoxazole |
19 (65.5) |
1 (3.4) |
9 (31) |
| Nitroxolinum |
25 (86.2) |
1 (3.4) |
3 (10.3) |
| Furamag |
17 (58.6) |
4 (13.8) |
8 (27.6) |
| Amikacin |
21 (72.4) |
0 (0.0) |
8 (27.6) |
| Gentamicin |
16 (55.2) |
1 (3.4) |
12 (41.4) |
| Nitrofurantoin |
16 (55.2) |
2 (6.9) |
11 (37.9) |
| Meropenem |
28 (96.6) |
0 (0.0) |
1 (3.4) |
| Furagin |
17 (58.6) |
4 (13.8) |
8 (27.6) |
| Fosfomycin |
21 (72.4) |
0 (0.0) |
8 (27.6) |